Zobrazeno 1 - 10
of 152
pro vyhledávání: '"Z Krastev"'
Publikováno v:
International Journal of Nephrology, Vol 2012 (2012)
Introduction. There are limited studies on simultaneous evaluation of liver and renal blood flow using Doppler methods. We evaluated and compared the changes of liver and renal Doppler US parameters in patients with liver cirrhosis according to the d
Externí odkaz:
https://doaj.org/article/ca176e4df2ea42a0a1dd4adb80439b41
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Anticancer research. 29(12)
Patients with concomitant hepatitis C (HCV) and B (HBV) infection are difficult to treat due to lack of medicines that control these viral infections and the high risk of hepatocellular carcinoma. Currently, there are insufficient data regarding the
Autor:
D, Jelev, Z, Krastev
Publikováno v:
Hepato-gastroenterology. 50
A 40-year-old viremic woman with HBV related liver cirrhosis (Child-Plugh - C) received 100 mg lamivudine daily for 24 months. Initially the patient was with hepato-splenomegaly, marked ascites and mild jaundice. There were no signs of portal encepha
Publikováno v:
Hepato-gastroenterology. 50(53)
A case of an inoperable hepatocellular carcinoma due to liver cirrhosis is presented. Surgical treatment was not clinically warranted. So we decided to induce tumor necrosis by intratumoral injections of 10 mL of ethanol followed by two treatments wi
Publikováno v:
Hepato-gastroenterology. 50(52)
Some positive results have been observed after interleukin-2 treatment, especially in melanoma, and pulmonary metastasis of renal carcinoma. The aim of the following article is to analyze the response to interleukin-2 in patients with non-melanoma an
Publikováno v:
Hepato-gastroenterology. 46(30)
We evaluated the effect of immunomodulatory treatment with levamisole in HBeAg positive or anti-HBe positive patients with chronic HBV infection and ongoing viral replication. The majority of patients had an expected poor response to IFN-alpha.Twenty